Medicare Will Pay for Zepbound for Some Patients. The Costs Could Be Huge.
The government-funded insurance plan will now pay for the drug for patients with obstructive sleep apnea, a condition that ...
Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...
Eli Lilly: Still Expensive As Earnings Near, But Not Worthy Of A Downgrade
Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.
FiercePharma3d
Wegovy and Zepbound tipped to fuel $20B boom in heart failure market
GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...
Trump's Ozempic tariffs, Zepbound on Medicare, and rising drug prices: Pharma news roundup
El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...
STAT1d
Pharmalittle: We’re reading about pharma layoffs, Moderna gambling on China, and more
The number of layoffs in the U.S. pharmaceutical industry exceeded 14,000 last year, a 9% increase from 2023 ...
Hosted on MSN4d
My PMDD Ruled My Life. Then I Got on Zepbound.
I had been taking Zepbound for about six months when it clicked. My period — the monster that turned me from a functioning ...